A novel mesenchymal stem cell-based regimen for acute myeloid leukemia differentiation therapy.
Sun L, Yang N, Chen B, Bei Y, Kang Z, Zhang C, Zhang N, Xu P, Yang W, Wei J, Ke J, Sun W, Li X, Shen P.
Sun L, et al. Among authors: kang z.
Acta Pharm Sin B. 2023 Jul;13(7):3027-3042. doi: 10.1016/j.apsb.2023.05.007. Epub 2023 May 16.
Acta Pharm Sin B. 2023.
PMID: 37521858
Free PMC article.